Business · 01/10/2026
FDA Renews Dermatologic and Ophthalmic Drugs Advisory Committee
The FDA is renewing the Dermatologic and Ophthalmic Drugs Advisory Committee under the leadership of the Commissioner of Food and Drugs, effective immediately.
Original source language: Federal Register — Health and Human ServicesOpen original release →